PGNY.NASDAQProgyny, INC

Form 4: Progyny Director Scott Cheryl Acquires Shares

Sentiment:

Insider Transaction Filing


Progyny, Inc. Director Cheryl Scott reported a transaction involving the acquisition of common stock and stock options.

Summary

  • Director Cheryl Scott acquired 5,660 shares of Progyny, Inc. common stock on May 21, 2026, with no cost indicated.
  • Following this transaction, Scott beneficially owns 19,772 shares of common stock.
  • Additionally, Scott acquired a stock option right to buy 27,119 shares of common stock at an exercise price of $24.69.
  • These stock options are exercisable and will vest on May 21, 2027, or the day before the issuer's first annual meeting of stockholders after the grant date, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction related to compensation and does not inherently signal a change in the company's financial performance or strategic direction.

Positives

  • Director Cheryl Scott has increased her beneficial ownership of Progyny, Inc. common stock.
  • Acquisition of stock options indicates a long-term commitment and potential future equity gain for the director.

Future Outlook

The stock options acquired by Director Scott are subject to vesting conditions tied to continued service and future annual meetings, indicating a forward-looking incentive structure.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by a director, are common in the health services and benefits administration sector as companies utilize equity-based compensation to align executive and director interests with shareholders.

Stakeholder Impact

  • Shareholders: The acquisition of stock by a director can be seen as a positive signal of confidence in the company's future prospects. The vesting schedule for RSUs and options aligns the director's incentives with long-term shareholder value.

Next Steps

  • Vesting of restricted stock units and stock options on May 21, 2027, or the day before the issuer's first annual meeting of stockholders following the grant date, subject to continued service.

Key Dates

DateDescription
05/21/2026Transaction date for acquisition of common stock and stock options.
05/20/2036Expiration date for stock options.
05/21/2027Vesting date for restricted stock units and stock options.
05/26/2026Date of signature for the filing.

Keywords

Progyny Inc, PGNY, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.